NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
Clinical Trials
7 trialsNCT00499694 2018-06-12
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT01289067 2018-02-13
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00450970 2012-08-17
SPERA
Agennix
Phase 3 Terminated
NCT00069745 2012-08-07
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Agennix
Phase 3 Completed
NCT00313456 2012-05-10
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
Agennix
Phase 1 Terminated
NCT00480623 2012-03-23
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Agennix
Phase 1 Terminated